Cleaved Diagnostics
PrivateLast Round
Grant
Aug 13, 2025
Total Funding Raised
$355,000
Company Overview
Cleaved Diagnostics is a biotechnology company that develops rapid, ultra-sensitive pathogen detection platforms using CRISPR-Cas12a technology for point-of-care diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleaved Diagnostics Comparables
Compare Cleaved Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ginkgo Bioworks | 68% | |
| Danaher Corporation | 66% | |
| Mammoth Biosciences | 63% |
Cleaved Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 13, 2025 | ||||
| Grant | Sep 1, 2024 |
Cleaved Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tulane University Innovation Institute | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 13, 2025
$305K awarded by the National Science Foundation.
- Sep 1, 2024
$50K grant received from Tulane University Innovation Institute.
Cleaved Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cleaved Diagnostics's valuation, stock price, and market status.
Is Cleaved Diagnostics a public or private company?
Cleaved Diagnostics is a private company.
What is the current stock price of Cleaved Diagnostics?
Cleaved Diagnostics is a private company, so its shares have no public market price. Caplight tracks Cleaved Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleaved Diagnostics worth (valuation)?
Valuation information for Cleaved Diagnostics is not publicly available.
Can I buy Cleaved Diagnostics stock?
Cleaved Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleaved Diagnostics's last funding round?
Cleaved Diagnostics's most recent funding round was Grant on August 13, 2025.
Who are the main investors in Cleaved Diagnostics?
Key investors in Cleaved Diagnostics include Tulane University Innovation Institute, National Science Foundation.
Will Cleaved Diagnostics IPO soon?
No public IPO plans have been announced for Cleaved Diagnostics.
How can I track Cleaved Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in Cleaved Diagnostics's shares on secondary markets.